797 results
Page 2 of 40
SC TO-T
EX-99
m6tehqv5j6 o2l7glcde
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
5j2shc
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
8bru59g5h2zv
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
rdf0r0qd5 4ha8l7
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.2
zyr8g wfyr
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
n8lr5w
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.3
ueyz8lcg 3dh4a9
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.1
s3vpkjveqmbt4o2 6kjx
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
n5towzga 63b2r0g
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
nl1mt sl6hqolz3wl0
22 Dec 23
Additional proxy materials by non-management
4:36pm
DFAN14A
blhqv
22 Dec 23
Additional proxy materials by non-management
4:21pm
DFAN14A
EX-99.1
bidqtphjm35
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
q8x nks1eqw
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-99.1
f9xmybj4i71
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
424B5
m5igvrn
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
iofk0 ker
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
ky5xl6ajwy26qsh
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
kfrwkppv
10 Oct 23
Additional proxy materials by non-management
6:48am